Phase II Evaluation of Recombinant Interferon-β (LFN-βser) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group Study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
1976 • 527 citations
Relation between Exposure to Asbestos and Mesothelioma
1965 • 343 citations
Malignant Mesothelioma
1980 • 170 citations
Pleural Mesothelioma: Clinical Features and Therapeutic Implications
1977 • 161 citations
LOCALIZED FIBROUS MESOTHELIOMA OF THE PLEURA
1952 • 143 citations
Malignant Mesothelioma
1978 • 63 citations
Phase I evaluation of a synthetic mutant of beta-interferon.
1985 • 60 citations
Solitary (Localized) Pleural Mesothelioma
1971 • 44 citations
Effect of Recombinant Interferon-βser on Primary Human Tumor Colony-Forming Units
1988 • 15 citations
Malignant mesotheliomas and chemotherapy
1980 • 11 citations
Phase I study of recombinant beta-interferon given by four-hour infusion.
1987 • 8 citations